Melvin Capital Has Another Bad January After Raising $6 Billion in 2021

image

(Bloomberg) — Melvin Capital Management, after raising almost $6 billion last year, just booked another January of steep losses.

Gabe Plotkin’s hedge fund tumbled 15% last month, according to a person familiar with the matter, compared with a 9% drop for the tech-heavy Nasdaq Composite Index and 5.3% decline for the S&P 500.

The first month of last year was even worse. The fund plunged almost 55%, erasing roughly $7 billion of capital, as short wagers on meme stocks such as GameStop Corp. turned sour.

Even after gaining about 33% in the months that followed, Plotkin was still down 39.3% for the year. He now needs to gain about 94% to break even.

Melvin pulled in $3.2 billion of fresh capital later in the year, according to filings, after raising $2.75 billion in January from investors including Ken Griffin’s Citadel and Steve Cohen’s Point72 Asset Management.

Read more: Citadel, Point72 Back Melvin With $2.75 Billion After Losses

The Wall Street Journal reported last month’s returns earlier Wednesday.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More